Early Patient Removal of Urinary Catheters After Urogynecologic Surgery
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Mar 27, 2024
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether women who have had certain types of surgery for bladder issues can safely remove their urinary catheters at home just one day after surgery, instead of waiting three to four days. The researchers want to find out if removing the catheter earlier leads to similar outcomes in terms of urinary retention, infections, and pain at the catheter site as the standard method.
To be eligible for this trial, participants must be women aged 36 to 75 who are undergoing surgery for prolapse or to prevent urinary leakage and have trouble urinating after their procedure. Unfortunately, women who are pregnant, do not speak English, or had specific complications during surgery cannot participate. If you join the study, you will be guided on how to safely remove the catheter at home, and researchers will monitor your recovery to ensure everything goes smoothly. This study aims to make recovery easier and more comfortable for women after urogynecologic surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All women undergoing prolapse or anti-incontinence surgery who fail their voiding trials prior to discharge.
- Exclusion Criteria:
- • Non-English speaking (due to limited resources to consent non-English speaking patients)
- • Pregnant
- • Postvoid residual (PVR) \>150 mL or dependent upon catheterization to void pre-operatively
- • Urethral bulking injection surgery
- • Intra-operative complication requiring prolonged catheterization
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Raleigh, North Carolina, United States
Patients applied
Trial Officials
Lauren Tholemeier, MD
Principal Investigator
University of North Carollina at Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported